Advanced 3D Bioprinted Tissue Models: Revolutionizing Research, Drug Discovery, and Toxicology

Abstract

The advent of 3D bioprinting has ushered in a new era in biomedical research by providing previously unattainable chances to replicate complex tissue models that replicate natural physiological circumstances. An overview of the effects of sophisticated 3D bioprinted tissue models on toxicology, research, and drug development is given in this study. With 3D bioprinted tissue models, researchers can study tissue behavior in controlled environments to better understand human physiology. These models greatly enhance drug development by providing more physiologically appropriate platforms for evaluating the toxicity and efficacy of medicines by mimicking the microarchitecture of tissues. Additionally, the technique may lessen the need for conventional animal models. 3D bioprinted tissues contribute substantially to toxicity research by providing a scalable and realistic platform for assessing the adverse effects of different chemicals. Translational potential is increased by including patient-specific cells, which promotes personalized treatment and closes the gap between preclinical and clinical research. 3D bioprinting processes are briefly covered in this overview, with a focus on bioink formulation, scaffold design, and cellular inclusion. Standardization and scalability are recognized as challenges, and integration with high-throughput screening is one of the potential opportunities examined. In conclusion, the application of 3D bioprinting in toxicology, research, and drug development has the potential to influence biomedical research in the future by encouraging the creation of safer and more efficient treatment procedures.